Dear Editor, we would like to share ideas on the publication “Diabetic ketoacidosis precipitated by atypical coronavirus disease in a newly diagnosed diabetic girl”.1 Albuali and AlGhamdi reported an interesting case and concluded that “We conclude that SARS-CoV-2 may trigger the onset of T1DM and may precipitate the occurrence of DKA in paediatric diabetic patients, even in the absence of respiratory symptoms”.1 Ketoacidosis is an important endocrine problem that might occur in a patient with COVID-19. Affected cases might have diabetes type 1 or 2.2 The problem is also observable in cases where blood glucose is not that high (<300 mg/dL).3 Regarding the pathomechanism, according to a publication by Vitale et al., a direct toxic effect of the SASR CoV2 on the pancreatic islets or accelerated inflammatory response is proposed as promoting ketosis.3 However, as seen in the present case, an overt inflammatory parameter is usually not seen, and it might not explain occurrence in a case with euglycemic status. Another possible pathological process that should be mentioned is hyperviscosity induced by COVID-19. In COVID-19, a high blood viscosity can occur,4 and hyperviscosity can further induce ketoacidosis.5,6
Source of funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Conflict of interest
The authors have no conflict of interest to declare.
Ethical approval
The authors confirm that this letter has been conducted in accordance with COPE rules and regulations. Given the nature of the letter, the IRB review was not required.
Authors contributions
Both authors have contributed equally and met all four of the following criteria: Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work AND drafting the work or revising it critically for important intellectual content AND final approval of the version to be published AND agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All authors have critically reviewed and approved the final draft and are responsible for the content and similarity index of the manuscript.
Footnotes
Peer review under responsibility of Taibah University.
References
- 1.Albuali W.H., AlGhamdi N.A. Diabetic ketoacidosis precipitated by atypical coronavirus disease in a newly diagnosed diabetic girl. J Taibah Univ Med Sci. 2021 Aug;16(4):628–631. doi: 10.1016/j.jtumed.2021.01.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Gorthi R.S., Kamel G., Dhindsa S., Nayak R.P. COVID-19 presenting with diabetic ketoacidosis: a case series. AACE Clin Case Rep. 2021 Jan-Feb;7(1):6–9. doi: 10.1016/j.aace.2020.11.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Vitale R.J., Valtis Y.K., McDonnell M.E., Palermo N.E., Fisher N.D.L. Euglycemic diabetic ketoacidosis with COVID-19 infection in patients with type 2 diabetes taking SGLT2 inhibitors. AACE Clin Case Rep. Jan-Feb 2021;7(1):10–13. doi: 10.1016/j.aace.2020.11.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Joob B., Wiwanitkit V. Blood viscosity of COVID-19 patient: a preliminary report. Am J Blood Res. 2021 Feb 15;11(1):93–95. [PMC free article] [PubMed] [Google Scholar]
- 5.Jones R., McMurray E., Robinson O. Stroke as the presenting feature of new onset diabetes in a young man. BMJ Case Rep. 2014 Jun 25:2014. doi: 10.1136/bcr-2014-204251. bcr2014204251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Emmett M., Narins R.G. Clinical use of the anion gap. Medicine (Baltim) 1977 Jan;56(1):38–54. [PubMed] [Google Scholar]